Vaccine Bridging Data Could Be Collected During FDA Review - Kaiser's Black
Executive Summary
Additional safety and efficacy information for vaccines could be collected during FDA's review and approval decision process, Kaiser Permanente Vaccine Study Center Co-Director Steven Black, MD, suggested at the International Symposium on Combination Vaccines Feb. 3 in Bethesda, Md.